HAP Trading’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-139,962
Closed -$3.77M 1864
2022
Q3
$3.55M Buy
139,962
+70,725
+102% +$2.48M 0.24% 98
2022
Q2
$2.3M Buy
69,237
+59,035
+579% +$2.51M 0.12% 155
2022
Q1
$736K Sell
10,202
-7,776
-43% -$560K 0.03% 429
2021
Q4
$1.65M Sell
17,978
-18,442
-51% -$2.2M 0.05% 347
2021
Q3
$4.62M Sell
36,420
-12,041
-25% -$1.75M 0.15% 140
2021
Q2
$8.06M Buy
+48,461
New +$7.85M 0.25% 82
2021
Q1
Sell
-43,691
Closed -$8.74M 2344
2020
Q4
$8.74M Buy
+43,691
New +$8.88M 0.25% 63
2018
Q4
Sell
-19,650
Closed -$1.7M 1286
2018
Q3
$1.7M Buy
+19,650
New +$1.4M 0.11% 154

Other funds holding TDOC

HAP Trading's TDOC Position: Q4 2022 in Review

HAP Trading sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 139,962 shares — an estimated $3.77M sold.

HAP Trading first reported a position in TDOC in Q3 2018 and held it in 8 quarters. The position peaked at $8.74M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • HAP Trading reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • HAP Trading sold 139,962 Teladoc Health shares in Q4 2022, an estimated $3.77M.
  • HAP Trading first reported a position in Teladoc Health in Q3 2018 and held it in 8 quarters.
  • HAP Trading's Teladoc Health position peaked at $8.74M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on HAP Trading's 13F filing for Q4 2022, filed 14 Feb 2023.